Robert A. Kowatch, MD, Ph.D.

Dr. Robert Kowatch is Professor of Psychiatry in the Center for Innovation in Pediatric Practice at the Research Institute at Nationwide Children’s Hospital. He completed his internship in internal medicine at The Graduate Hospital of the University of Pennsylvania in Philadelphia and his residency in general psychiatry at the Hospital of the University of Pennsylvania. He completed his Child and Adolescent Psychiatry Fellowship at Hahnemann University, Philadelphia, PA. In 2006 he earned a Ph.D. in Cognition and Neuroscience at the University of Texas at Dallas. Dr. Kowatch has authored or co-authored more than 60 articles, 14 book chapters, and two books. He has published in the areas of the diagnosis and treatment of children and adolescents with bipolar disorders, sleep disorders and depression. His articles have been published in the Journal of American Academy of Child and Adolescent Psychiatry, Neuropsychopharmacology, Archives of General Psychiatry, and Journal of Child Neurology, among others. His clinical and research interests are in the biology and treatment of pediatric mood disorders.

Gender:

• Male

Languages Spoken:

• English

Research Center:

• Center for Innovation in Pediatric Practice

Areas of Interest:

• Biology and treatment of pediatric mood disorders

Research Funding*:

• Longitudinal Assessment of Manic Symptoms (LAMS2): LAMS is a collaborative, multi-site, NIMH-funded, collaborative R01 that proposes to longitudinally investigate “elevated symptoms of mania” (ESM) in children and adolescents. This project is being conducted at four sites over five years: Case Western Reserve University/University Hospitals of Cleveland (Case/UHC), Western Psychiatric Institute and Clinic (WPIC), Cincinnati Children's Hospital Medical Center/University of Cincinnati (CCHMC/UC), and Ohio State University.
• Family Focused Therapy (R01): This 5-year study is testing the efficacy of a promising new intervention for BP adolescents, family-focused treatment (FFT), as adjunct to carefully controlled pharmacotherapy in a 3-site randomized trial (U. of Colorado [coordinating site; D. Miklowitz, PI], U. of Pittsburgh [D. Axelson, PI], and Cinn. Childrens [R. Kowatch, PI]). Outcome assessments include the K-SADS and the Longitudinal Interval Follow-up Evaluation given to parents and adolescents every 3–6 months over 2 years.

Medical School

• Chicago Medical School
  Date Completed: 07/30/1980

Internship

• The Graduate Hospital of the University of Pennsyl
  Date Completed: 06/30/1981

Residency

• The Graduate Hospital of the University of Pennsyl
  Date Completed: 06/30/1983

Fellowship

• Hahnemann University Hospital
  Date Completed: 06/30/1985

Department:

• Psychiatry

Speciality:

• Child and Adolescent Psychiatry
  
• Psychiatry
  
• Sleep Medicine
  

Date of Appointment at Nationwide Children’s Hospital:

• 09/01/2011

2000–2011

• Professor of Psychiatry and Pediatrics, Director of Psychiatry Research, Cincinnati Children's Hospital Medical Center

1995–2000

• Associate Professor of Psychiatry, The University of Texas Southwestern Medical School at Dallas

1989–1995

• Assistant Professor of Psychiatry, University of Texas Southwestern Medical Center at Dallas; Associate Director, Psychiatric Inpatient Unit, Children's Medical Center of Dallas

• Hafeman DM, Bebko G, Bertocci M, Hinze A, Gill MK Axelson DA, Birmaher B, Demeter C, Findling RL, Kowatch R, Phillips ML. 2012. Relationship between parental history of mania and amygdala activity during implicit processing of emotional faces.  Biological Psychiatry. Vol. 71, no. 8. (April): 212S-213S.
• Bebko GM, Bertocci MA, Hinze AK, Findling RL, Kowatch RA, Birmaher B, Axelson D, Horwitz SM, Fristad MA, Phillips ML. 2012. Neural Correlates of Reward Processing in Youth with Elevated Symptoms of Mania.  Biological Psychiatry. Vol. 71, no. 8. (April): 208S-208S.
• Bebko,Genna,M; Bertocci,Michele,A; Hinze,Amanda,K; Findling,Robert,L; Kowatch,Robert,A; Birmaher,Boris; Axelson,David; Horwitz,Sarah,M; Fristad,Mary,A; Phillips,Mary,L. 2012. Neural Correlates of Reward Processing in Youth with Elevated Symptoms of Mania.  BIOLOGICAL PSYCHIATRY. Vol. 71, no. 8. (April): 208S-208S.
• Hafeman,Danella,M; Bebko,Genna; Bertocci,Michele; Hinze,Amanda; Gill,Mary,Kay; Axelson,David,A; Birmaher,Boris; Demeter,Christine; Findling,Robert,L; Kowatch,Robert; Phillips,Mary,L. 2012. Relationship between Parental History of Mania and Amygdala Activity During Implicit Processing of Emotional Faces.  BIOLOGICAL PSYCHIATRY. Vol. 71, no. 8. (April): 212S-213S.
• Bertocci,Michele,A; Bebko,Genna,M; Hinze,Amada; Findling,Robert,L; Kowatch,Robert,A; Birmaher,Boris; Axelson,David,A; Horowitz,Sarah,M; Fristad,Mary,A; Phillips,Mary,L. 2012. Gender Differences in Relationships Between Elevated Symptoms of Mania and Anterior Cingulate and Dorsolateral Prefrontal Cortical Activity in Youth.  BIOLOGICAL PSYCHIATRY. Vol. 71, no. 8. (April): 209S-209S.
• Bertocci MA, Bebko GM, Hinze A, Findling RL, Kowatch RA, Birmaher B, Axelson DA, Horowitz SM, Fristad MA, Phillips ML. 2012. Gender Differences in Relationships Between Elevated Symptoms of Mania and Anterior Cingulate and Dorsolateral Prefrontal Cortical Activity in Youth.  Biological Psychiatry. Vol. 71, no. 8. (April): 209S-209S.
• Arnold LE, Demeter C, Mount K, Frazier TW, Youngstrom EA, Fristad M, Birmaher B, Findling RL, Horwitz SM, Kowatch R, Axelson DA. 2011. Pediatric bipolar spectrum disorder and ADHD: comparison and comorbidity in the LAMS clinical sample.  Bipolar Disord. Vol. 13, no. 5-6. (August): 509-521.
• Arnold LE, Demeter C, Mount K, Frazier TW, Youngstrom EA, Fristad M, Birmaher. 2011. Pediatric bipolar spectrum disorder and ADHD: comparison and comorbidity in the LAMS clinical sample.  Bipolar Disord. Vol. 13, no. 5-6. (August): 509-521.
• Findling RL, Horwitz SM, Birmaher B, Kowatch RA, Fristad MA, Youngstrom EA,Frazier TW, Axelson D, Ryan N, Demeter CA, Depew J, Fields B, Gill MK, Deyling EA, Rowles BM, Arnold LE. 2011. Clinical characteristics of children receiving antipsychotic medication.  J Child Adolesc Psychopharmacol. Vol. 21, no. 4. (August): 311-319.
• Findling, R.L., Horwitz, S.M., Birmaher, B., Kowatch, R.A., Fristad, M.A., Youngstrom, E.A., Frazier, T.W., Axelson, D., Ryan, N., Demeter, C.A., Depew, J., Fields, B., Gill, M.K., Deyling, E.A., Rowles BM, Arnold LE. (2011) Clinical characteristics of children receiving antipsychotic medication. Journal of Child & Adolescent Psychopharmacology, Aug 21(4):311-319. PubMed ID: 21851189
• Frazier TW, Youngstrom EA, Horwitz SM, Demeter CA, Fristad MA, Arnold LE, Birmaher B, Kowatch RA, Axelson D, Ryan N, Gill MK, Findling RL. 2011. Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders.  J Clin Psychiatry. Vol. 72, no. 6. (June): 846-853.
• Findling, R.L., Kafantaris, V., Pavuluri, M., McNamara, N.K., McClellan, J., Frazier, J.A., Sikich, L., Kowatch, R.A., Lingler, J., Faber, J., Rowles, B.M., Clemons, T.E., & Taylor-Zapata, P. (2011) Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. Journal of Child & Adolescent Psychopharmacology, Jun 21(3):195-205. PubMed ID: 21663422
• Mendenhall, A.N., Demeter, C., Findling, R.L., Frazier, T.W., Fristad, M.A., Youngstrom, E.A., Arnold, L.E., Birmaher, B., Gill, M.K., Axelson, D., Kowatch, R.A., & Horwitz, S.M. (2011) Mental health service use by children with serious emotional and behavioral disturbance: Results from the LAMS study. Psychiatric Services, Jun 62(6):650-658. PubMed ID: 21632735
• Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Rowles BM, Clemons TE, Taylor-Zapata P. 2011. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.  J Child Adolesc Psychopharmacol. Vol. 21, no. 3. (June): 195-205.
• Mendenhall AN, Demeter C, Findling RL, Frazier TW, Fristad MA, Youngstrom EA, Arnold LE, Birmaher B, Gill MK, Axelson D, Kowatch RA, Horwitz SM. 2011. Mental health service use by children with serious emotional and behavioral disturbance: Results from the LAMS study.  Psychiatr Serv. Vol. 62, no. 6. (June): 650-658.
• Frazier, T.W., Youngstrom, E.A., McCue-Horwitz, S., Demeter, C.A., Fristad, M.A., Arnold, L.E., Birmaher, B., Kowatch, R.A., Axelson, D., Ryan, N., Gill, M.K., & Findling, R.L. (2011) Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders. Journal of Clinical Psychiatry. Jun 72(6):846-853. PubMed ID: 21457674
• Axelson, D.A., Birmaher, B., Findling, R.L., Fristad, M.A., Kowatch, R.A., Youngstrom, E.A., Arnold, E.L., Goldstein, B.I., Goldstein, T.R., Chang, K.D., DelBello, M.P., Ryan, N.D., & Diler, R.S. (2011) Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Journal of Clinical Psychiatry, May 3 (epub ahead of print) PubMed ID: 21672494
• Kowatch RA, Monroe E, Delgado SV. 2011. Not all mood swings are bipolar: How to evaluate children with mood lability.  Current Psychiatry. Vol. 2, no. 10. (February): 38-52.
• Findling RL, Youngstrom EA, Fristad MA, Birmaher B, Kowatch RA, Arnold LE, Frazier TW, Axelson D, Ryan N, Demeter CA, Gill MK, Fields B, Depew J, Kennedy SM, Marsh L, Rowles BM, Horwitz SM. 2010. Characteristics of children with elevated symptoms of mania: The longitudinal assessment of manic symptoms (LAMS) study.  J Clin Psychiatry. Vol. 71, no. 12. (December): 1664-1672.
• Horwitz SM, Demeter CA, Pagano ME, Youngstrom EA, Fristad MA, Arnold LE, Birmaher B, Gill MK, Axelson D, Kowatch RA, Frazier TW, Findling RL. 2010. Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results.  J Clin Psychiatry. Vol. 71, no. 11. (November): 1511-1517.
• Findling RL, Landersdorfer CB, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, Frazier JA, Sikich L, Kowatch R, Lingler J, Faber J, Taylor-Zapata P, Jusko WJ. 2010. First-dose pharmacokinetics of lithium carbonate in children and adolescents.  J Clin Psychopharmacol. Vol. 30, no. 4. (August): 404-410.
• Harris E, Eng HY, Kowatch R, Delgado SV, Saldaña SN. 2010. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.  J Child Adolesc Psychopharmacol. Vol. 20, no. 4. (August): 347-353.
• Danielyan,Arman; Cannon,Michael; Kowatch,Robert,A. 2010. An Open Prospective Trial of Aripiprazole in Children and Adolescents with Bipolar I Disorder.  BIOLOGICAL PSYCHIATRY. Vol. 67, no. 9. (May): 233S-233S.
• Danielyan,Arman; Cannon,Michael; Kowatch,Robert,A. 2010. An Open Prospective Trial of Aripiprazole in Children and Adolescents with Bipolar I Disorder.  BIOLOGICAL PSYCHIATRY. Vol. 67, no. 9. (May): 233S-233S.
• Pfeifer JC, Kowatch RA, DelBello MP. 2010. Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.  CNS Drugs. Vol. 24, no. 7. (January): 575-593.
• Danner S, Fristad MA, Arnold LE, Youngstrom EA, Birmaher B, Horwitz SM, Demeter C, Findling RL, Kowatch RA; LAMS Group. 2009. Early-onset bipolar spectrum disorders: diagnostic issues.  Clin Child Fam Psychol Rev. Vol. 12, no. 3. (September): 271-293.
• Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M. 2009. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.  J Am Acad Child Adolesc Psychiatry. Vol. 48, no. 5. (May): 519-532.
• Nandagopal JJ, DelBello MP, Kowatch R. 2009. Pharmacologic treatment of pediatric bipolar disorder.  Child Adolesc Psychiatr Clin N Am. Vol. 18, no. 2. (April): 455-?.
• Kowatch,Joyce,A. 2009. ANTIPSYCHOTICS AND THE ELDERLY.  AMERICAN JOURNAL OF NURSING. Vol. 109, no. 3. (March): 13-14.
• Carlson GA, Findling RL, Post RM, Birmaher B, Blumberg HP, Correll C, DelBello MP, Fristad M, Frazier J, Hammen C, Hinshaw SP, Kowatch R, Leibenluft E, Meyer SE, Pavuluri MN, Wagner KD, Tohen M. 2009. AACAP 2006 Research Forum--Advancing research in early-onset bipolar disorder: barriers and suggestions.  J Child Adolesc Psychopharmacol. Vol. 19, no. 1. (February): 3-12.
• Findling RL, Frazier JA, Kafantaris V, Kowatch R, McClellan J, Pavuluri M, Sikich L, Hlastala S, Hooper SR, Demeter CA, Bedoya D, Brownstein B, Taylor-Zapata P. 2008. The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.  Child Adolesc Psychiatry Ment Health. Vol. 2, no. 1. (January): e21.
• Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, Luby JL, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah CH. 2007. Psychopharmacological treatment for very young children: Contexts and guidelines.  J Am Acad Child Adolesc Psychiatry. Vol. 46, no. 12. (December): 1532-1572.
• Tohen,Mauricio; Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Wozniak,Janet; Kowatch,Robert; Wagner,Karen; Findling,Robert; Lin,Daniel; Robertson-Plouch,Carol; Xu,Wen; Dittman,Ralf; Biederman,Joe. 2007. Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension.  JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. Vol. 17, no. 6. (December): 882-882.
• Tohen,Mauricio; Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Wozniak,Janet; Kowatch,Robert; Wagner,Karen; Findling,Robert; Lin,Daniel; Robertson-Plouch,Carol; Xu,Wen; Dittman,Ralf; Biederman,Joe. 2007. Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension.  JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. Vol. 17, no. 6. (December): 882-882.
• Pfeifer JC, Kowatch RA, DelBello MP. 2007. The use of antipsychotics in children and adolescents with bipolar disorders.  Expert Opin Pharmacother. Vol. 8, no. 16. (November): 2673-2687.
• Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J. 2007. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.  Am J Psychiatry. Vol. 164, no. 10. (October): 1547-1556.
• Singh MK, Pfeifer JC, Barzman DH, Kowatch RA, DelBello MP. 2007. Medical management of pediatric mood disorders.  Pediatr Ann. Vol. 36, no. 9. (September): 552-563.
• Tohen,Mauricio; Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Wozniak,Janet; Kowatch,Robert; Wagner,Karen; Findling,Robert; Lin,Daniel; Robertson-Plouch,Carol; Xu,Wen; Dittmann,Ralf; Biederman,Joe. 2007. Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension.  PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. Vol. 16, no. August: S215-S215.
• Tohen,Mauricio; Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Wozniak,Janet; Kowatch,Robert; Wagner,Karen; Findling,Robert; Lin,Daniel; Robertson-Plouch,Carol; Xu,Wen; Dittmann,Ralf; Biederman,Joe. 2007. Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension.  PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. Vol. 16, no. August: S215-S215.
• Singh MK, Pfeifer JC, Barzman D, Kowatch RA, DelBello MP. 2007. Pharmacotherapy for child and adolescent mood disorders.  Psychiatr Ann. Vol. 37, no. 7. (July): 465-476.
• Robertson-Plouch,Carol; Carlson,Gabrielle; DelBello,Melissa; Findling,Robert; Kowatch,Robert; Schulz,S,Charles; Kryzhanovskaya,Ludmila; Xu,Wen; Carlson,Janice; Tohen,Mauricio. 2007. Changes in prolactin in adolescents with schizophrenia or bipolar disorder I during treatment with olanzapine: A pooled analysis of 4 studies.  BIOLOGICAL PSYCHIATRY. Vol. 61, no. 8. (April): 170S-170S.
• Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Findling,Robert; Kowatch,Robert; Schulz,S,Charles; Robertson-Plouch,Carol; Xu,Wen; Sethuraman,Gopalan; Carlson,Janice; Tohen,Mauricio. 2007. Changes in metabolic parameters in olanzapine-treated adolescents with schizophrenia or bipolar I disorder: A pooled analysis of 4 studies.  BIOLOGICAL PSYCHIATRY. Vol. 61, no. 8. (April): 170S-170S.
• Robertson-Plouch,Carol; Carlson,Gabrielle; DelBello,Melissa; Findling,Robert; Kowatch,Robert; Schulz,S,Charles; Kryzhanovskaya,Ludmila; Xu,Wen; Carlson,Janice; Tohen,Mauricio. 2007. Changes in prolactin in adolescents with schizophrenia or bipolar disorder I during treatment with olanzapine: A pooled analysis of 4 studies.  BIOLOGICAL PSYCHIATRY. Vol. 61, no. 8. (April): 170S-170S.
• Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Findling,Robert; Kowatch,Robert; Schulz,S,Charles; Robertson-Plouch,Carol; Xu,Wen; Sethuraman,Gopalan; Carlson,Janice; Tohen,Mauricio. 2007. Changes in metabolic parameters in olanzapine-treated adolescents with schizophrenia or bipolar I disorder: A pooled analysis of 4 studies.  BIOLOGICAL PSYCHIATRY. Vol. 61, no. 8. (April): 170S-170S.
• Danielyan A, Pathak S, Kowatch RA, Arszman SP, Johns ES. 2007. Clinical characteristics of bipolar disorder in very young children.  J Affect Disord. Vol. 97, no. 1-3. (January): 51-59.
• Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D'Souza J, Wamil A, Lehman RB, Berv D, Linden D. 2006. The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder - Reply.  Am J Psychiatry.. Vol. 163, no. 12. (December): 2196-2196.
• Singh MK, DelBello MP, Kowatch RA, Strakowski SM. 2006. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children.  Bipolar Disord.. Vol. 8, no. 6. (December): 710-720.
• Singh MK, DelBello MP, Kowatch R, Strakowski SM. 2006. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children.  Bipolar Disord. Vol. 8, no. 6. (November): 710-720.
• DelBello MP, Kowatch RA. 2006. Pharmacological interventions for bipolar youth: Developmental considerations.  Dev Psychopathol. Vol. 18, no. 4. (October): 1231-1246.
• Post RM, Findling RL, Kowatch R. 2006. Earlier recognition and treatment of prepubertal-onset bipolar disorder.  Psychiatr Ann. Vol. 36, no. 9. (September): 630-636.
• Tohen,Mauricio; Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Wozniak,Janet; Kowatch,Robert; Wagner,Karen; Findling,Robert; Lin,Daniel; Robertson-Plouch,Carol; Xu,Wen; Huang,Xiaohong; Dittmann,Ralf; Biederman,Joe. 2006. Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder. A 3-week randomized double-blind placebo-controlled study.  BIPOLAR DISORDERS. Vol. 8, no. August: 26-26.
• Tohen,Mauricio; Kryzhanovskaya,Ludmila; Carlson,Gabrielle; DelBello,Melissa; Wozniak,Janet; Kowatch,Robert; Wagner,Karen; Findling,Robert; Lin,Daniel; Robertson-Plouch,Carol; Xu,Wen; Huang,Xiaohong; Dittmann,Ralf; Biederman,Joe. 2006. Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder. A 3-week randomized double-blind placebo-controlled study.  BIPOLAR DISORDERS. Vol. 8, no. August: 26-26.
• Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann R, Biederman J. 2006. Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder; A 3-week randomized double-blind placebo-controlled study.  Pharmacoepidemiol Drug Saf. Vol. 15, no. August: S301-S302.
• Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann R, Biederman J. 2006. Efficacy of olanzapine for the treatment of acute mania in subtypes of adolescent patients: A 3-week randomized double-blind placebo-controlled study.  Bipolar Disord. Vol. 8, no. August: 26-26.
• Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D'Souza J, Wamil A, Lehman RB, Berv D, Linden D. 2006. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.  Am J Psychiatry. Vol. 163, no. 7. (July): 1179-1186.
• Patel NC, DelBello MP, Kowatch RA, Strakowski SM. 2006. Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.  J Child Adolesc Psychopharmacol. Vol. 16, no. 3. (June): 327-335.
• Patel NC, DelBello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, Strakowski SM. 2006. Open-label lithium for the treatment of adolescents with bipolar depression.  J Am Acad Child Adolesc Psychiatry. Vol. 45, no. 3. (March): 289-297.
• Kowatch RA, DelBello MP. 2006. Pediatric bipolar disorder: emerging diagnostic and treatment approaches.  Child Adolesc Psychiatr Clin N Am.. Vol. 15, no. 1. (January): 73-108.
• Delbello M, Versavel M, Ice K, Miceli J, Kowatch R, Keller D. 2006. Ziprasidone dosing study in pediatric patients with bipolar disorder, schizophrenia, or schizoaffective disorder.  Schizophr Res. Vol. 81, no. January: 80-81.
• Post RM, Kowatch RA. 2006. The health care crisis of childhood-onset bipolar illness: some recommendations for its amelioration.  J Clin Psychiatry. Vol. 67, no. 1. (January): 115-125.
• Fleck DE, Shear PK, Kowatch RA, Strakowski SM. 2005. Cognitive performance in bipolar disorder: A processing efficiency account.  Neuropsychopharmacology. Vol. 30, no. December: S111-S111.
• Barzman DH, DelBello MP, Kowatch RA, Warner J, Rofey D, Stanford K, Rappaport K, Daniels JP, Strakowski SM. 2005. Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders.  J Child Adolesc Psychopharmacol. Vol. 15, no. 6. (December): 931-937.
• Versavel M, DelBello MP, Ice K, Kowatch R, Keller D, Miceli J. 2005. Ziprasidone dosing study in pediatric patients with bipolar disorder, schizophrenia, or schizoaffective disorder.  Neuropsychopharmacology. Vol. 30, no. December: S122-S123.
• Kowatch RA, Youngstrom EA, Danielyan A, Findling RL. 2005. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents.  Bipolar Disord.. Vol. 7, no. 6. (December): 483-496.
• Barzman DH, Adler CM, DelBello MP, Stanford KE, Kowatch RA, Strakowski SM. 2005. Quetiapine efficacy in bipolar adolescents with depressive symptoms.  Neuropsychopharmacology. Vol. 30, no. December: S94-S94.
• Scheffer RE, Kowatch RA, Carmody T, Rush AJ. 2005. Conclusions inconsistent with results with amphetamines and divalproex - Reply.  Am J Psychiatry. Vol. 162, no. 11. (November): 2197-2198.
• Pathak S, Johns ES, Kowatch RA. 2005. Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: A case series.  J Child Adolesc Psychopharmacol. Vol. 15, no. 4. (August): 696-702.
• Kowatch RA, DelBello MP. 2005. Pharmacotherapy of children and adolescents with bipolar disorder.  Psychiatr Clin North Am. Vol. 28, no. 2. (June): 385-397.
• Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M; Child Psychiatric Workgroup on Bipolar Disorder. 2005. Treatment guidelines for children and adolescents with bipolar disorder.  J Am Acad Child Adolesc Psychiatry. Vol. 44, no. 3. (March): 213-235.
• Adler C, DelBello M, Kowatch R, Stanford KE, Welge J, Barzman D, Strakovski S. 2005. Double-blind comparison of divalproex versus quetiapine monotherapy for adolescent patients with mania.  European Psychiatry. Vol. 20, no. March: S139-S139.
• Scheffer RE, Kowatch RA, Carmody T, Rush AJ. 2005. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.  Am J Psychiatry. Vol. 162, no. 1. (January): 58-64.
• Danielyan A, Kowatch RA. 2005. Management options for bipolar disorder in children and adolescents.  Paediatr Drugs. Vol. 7, no. 5. (January): 277-294.
• DelBello MP, Kowatch RA, Adler CM, Welge JA, StrakowskiSM. 2004. A double-blind comparison of divalproex versus quetiapine for adolescent mania.  Neuropsychopharmacology. Vol. 29, no. December: S98-S99.
• Pathak S, Arszman SP, Danielyan A, Johns ES, Smirnov A, Kowatch RA. 2004. Psychotropic utilization and psychiatric presentation of hospitalized very young children.  J Child Adolesc Psychopharmacol. Vol. 14, no. 3. (October): 433-442.
• Pathak S, Arszman SP, Danielyan A, Johns ES, Smirnov A, Kowatch RA. 2004. Psychotropic utilization and clinical presentation of hospitalized very young children.  J Child Adolesc Psychopharmacol. Vol. 14, no. 3. (October): 433-442.
• Wilke M, Kowatch RA, DelBello MP, Mills NP, Holland SK. 2004. Voxel-based morphometry in adolescents with bipolar disorder: first results.  Psychiatry Res. Vol. 131, no. 1. (May): 57-69.
• Pathak S, Danielyan A, Kowatch RA. 2004. Successful treatment of trichotillomania with olanzapine augmentation in an adolescent.  J Child Adolesc Psychopharmacol. Vol. 14, no. 1. (March): 153-154.
• Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Campbell P, Strakowski SM. 2004. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: A retrospective chart review.  J Child Adolesc Psychopharmacol. Vol. 14, no. 4. (January): 593-600.
• Kowatch RA, DelBello MP. 2003. The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders.  CNS Spectr. Vol. 8, no. 4. (April): 273-280.
• Kowatch RA, DelBello MP, Wilke M, Mills N, Strakowski SM,. 2003. FMRI study of affect recognition and attention in pediatric bipolar subjects versus normal controls.  Biol Psychiatry. Vol. 53, no. 8. (April): 103S-103S.
• Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller EB, Wozniak J, Youngstrom EA. 2003. Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: Report of a consensus conference.  J Child Adolesc Psychopharmacol. Vol. 13, no. 1. (March): 13-27.
• Kowatch RA, DelBello MP, Findling RL. 2002. Depressive episodes in children and adolescents with bipolar disorders.  CLINICAL NEUROSCIENCE RESEARCH. Vol. 2, no. 3-4. (December): 158-160.
• DelBello MP, Kowatch RA, Warner J, Strakowski SM. 2002. Topiramate treatment for pediatric bipolar disorder: A retrospective chart review.  Biological Psychiatry. Vol. 51, no. 8. (April): 37S-37S.
• DelBello MP, Kowatch RA, Warner J, Schwiers ML, Rappaport KB, Daniels JP, Foster KD, Strakowski SM. 2002. Adjunctive topiramate treatment for pediatric bipolar disorder: A retrospective chart review.  J Child Adolesc Psychopharmacol. Vol. 12, no. 4. (January): 323-330.
• Biederman J, Birmaher B, Carlson GA, Chang KD, Fenton WS, Geller B, Hoagwood KE, Hyman SE, Kendler KS, Koretz DS, Kowatch RA, Kupfer DJ, Leibenluft E, Nakamura RK, Nottelmann ED, Stover E, Vitiello B, Weiblinger G, Weller E. 2001. National Institute of Mental Health research roundtable on prepubertal bipolar disorder.  J Am Acad Child Adolesc Psychiatry. Vol. 40, no. 8. (August): 871-878.
• Hughes CW, Emslie G, Kowatch R, Weinberg W, Rintelmann J, Rush AJ. 2000. Clinician, parent, and child prediction of medication or placebo in double-blind depression study.  Neuropsychopharmacology. Vol. 23, no. 5. (November): 591-594.
• Kowatch RA, Carmody TJ, Suppes T, Hume JH, Kromelis M, Emslie GJ, Weinberg WA. 2000. Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies.  Acta Neuropsychiatrica. Vol. 12, no. 3. (September): 145-149.
• Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ. 2000. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.  J Am Acad Child Adolesc Psychiatry. Vol. 39, no. 6. (June): 713-720.
• Armitage R, Emslie GJ, Hoffmann RF, Weinberg WA, Kowatch RA, Rintelmann J, Rush AJ. 2000. Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents.  Biol Psychiatry. Vol. 47, no. 4. (February): 338-350.
• Kowatch RA, Carmody TJ, Emslie GJ, Rintelmann JW, Hughes CW, Rush AJ. 1999. Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study.  J Affect Disord. Vol. 54, no. 3. (August): 269-276.
• Kowatch RA, Devous MD Sr, Harvey DC, Mayes TL, Trivedi MH, Emslie GJ, Weinberg WA. 1999. A SPECT HMPAO study of regional cerebral blood flow in depressed adolescents and normal controls.  Prog Neuropsychopharmacol Biol Psychiatry. Vol. 23, no. 4. (May): 643-656.
• Kowatch RA, Bucci JP. 1998. Mood stabilizers and anticonvulsants.  Pediatr Clin North Am. Vol. 45, no. 5. (October): 1173-1186.
• Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL. 1998. Fluoxetine in child and adolescent depression: acute and maintenance treatment.  Depress Anxiety. Vol. 7, no. 1. (January): 32-39.
• Prosser J, Hughes CW, Sheikha S, Kowatch RA, Kramer GL, Rosenbarger N, Trent J, Petty F. 1997. Plasma GABA in children and adolescents with mood, behavior, and comorbid mood and behavior disorders: A preliminary study.  J Child Adolesc Psychopharmacol. Vol. 7, no. 3. (January): 181-199.
• Rintelmann JW, Emslie GJ, Rush AJ, Varghese T, Gullion CM, Kowatch RA, Hughes CW. 1996. The effects of extended evaluation on depressive symptoms in children and adolescents.  J Affect Disord. Vol. 41, no. 2. (November): 149-156.
• Emslie GJ, Kennard BD, Kowatch RA. 1995. Affective disorders in children: diagnosis and management.  J Child Neurol. Vol. 10, no. 1. (January): S42-S49.
• Kowatch RA, Suppes T, Gilfillan SK, Fuentes RM, Grannemann BD, Emslie GJ. 1995. Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: A clinical case series.  J Child Adolesc Psychopharmacol. Vol. 5, no. 4. (January): 241-253.